Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Galera Raises $150m To Take Lead Drug From Phase III To NDA Submission

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.

Related Content

Keeping Track: Delay (For Celgene), Delay (For Allergan), Goose! (Approval For Lilly)

Mar 04 2018

VC Roundup: Flagship’s New Fund Designed To Raise Its Stake In Startups

Dec 23 2016

VC round-up: 8 December-4 January

Jan 08 2013

Pipeline Watch: Phase III Starts For BL-8040, Trigriluzole, MIN-101

Dec 22 2017

Related Companies

Galera Therapeutics, Inc.

Additional Topics

Financing Business Strategies StartUps and SMEs Companies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window